{"cik":"0001672619","ticker":"ELVN","name":"Enliven Therapeutics, Inc.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-04-27","last_filing_date":"2026-07-21","url":"/sec/cik-0001672619","insider_summary":{"total_transactions":52,"unique_insiders":6,"latest_transaction":"2026-07-17"},"recent_filings":[{"accession_number":"0001882764-26-000006","form_type":"4","form_type_family":"insider","doc_date":"2026-07-21","title":"4 — Enliven Therapeutics, Inc. — 2026-07-21","url_slug":"/sec/cik-0001672619/4/0001882764-26-000006","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001882764-26-000006-index.html"},{"accession_number":"0001701247-26-000011","form_type":"4","form_type_family":"insider","doc_date":"2026-07-21","title":"4 — Enliven Therapeutics, Inc. — 2026-07-21","url_slug":"/sec/cik-0001672619/4/0001701247-26-000011","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001701247-26-000011-index.html"},{"accession_number":"0001974158-26-000084","form_type":"144","form_type_family":"other","doc_date":"2026-07-17","title":"144 — Enliven Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001672619/144/0001974158-26-000084","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001974158-26-000084-index.html"},{"accession_number":"0000947871-26-000651","form_type":"SCHEDULE 13D/A","form_type_family":"other","doc_date":"2026-06-24","title":"SCHEDULE 13D/A — ORBIMED ADVISORS LLC — 2026-06-24","url_slug":"/sec/cik-0001055951/schedule-13d-a/0000947871-26-000651","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0000947871-26-000651-index.html"},{"accession_number":"0000947871-26-000653","form_type":"4","form_type_family":"insider","doc_date":"2026-06-24","title":"4 — ORBIMED ADVISORS LLC — 2026-06-24","url_slug":"/sec/cik-0001055951/4/0000947871-26-000653","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0000947871-26-000653-index.html"},{"accession_number":"0001172661-26-002461","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-06-22","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001672619/schedule-13g-a/0001172661-26-002461","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001172661-26-002461-index.html"},{"accession_number":"0001882764-26-000005","form_type":"4","form_type_family":"insider","doc_date":"2026-06-22","title":"4 — Enliven Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001672619/4/0001882764-26-000005","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001882764-26-000005-index.html"},{"accession_number":"0001701247-26-000010","form_type":"4","form_type_family":"insider","doc_date":"2026-06-22","title":"4 — Enliven Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001672619/4/0001701247-26-000010","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001701247-26-000010-index.html"},{"accession_number":"0000947871-26-000648","form_type":"144","form_type_family":"other","doc_date":"2026-06-22","title":"144 — ORBIMED CAPITAL LLC — 2026-06-22","url_slug":"/sec/cik-0001157524/144/0000947871-26-000648","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0000947871-26-000648-index.html"},{"accession_number":"0000947871-26-000650","form_type":"144","form_type_family":"other","doc_date":"2026-06-22","title":"144 — ORBIMED ADVISORS LLC — 2026-06-22","url_slug":"/sec/cik-0001055951/144/0000947871-26-000650","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0000947871-26-000650-index.html"},{"accession_number":"0000947871-26-000649","form_type":"144","form_type_family":"other","doc_date":"2026-06-22","title":"144 — ORBIMED ADVISORS LLC — 2026-06-22","url_slug":"/sec/cik-0001055951/144/0000947871-26-000649","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0000947871-26-000649-index.html"},{"accession_number":"0001974158-26-000074","form_type":"144","form_type_family":"other","doc_date":"2026-06-17","title":"144 — Enliven Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001672619/144/0001974158-26-000074","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001974158-26-000074-index.html"},{"accession_number":"0001193125-26-269635","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-12","title":"8-K — Enliven Therapeutics, Inc. — 2026-06-12","url_slug":"/sec/cik-0001672619/8-k/0001193125-26-269635","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-269635-index.html"},{"accession_number":"0001193125-26-269621","form_type":"424B5","form_type_family":"registration","doc_date":"2026-06-12","title":"424B5 — Enliven Therapeutics, Inc. — 2026-06-12","url_slug":"/sec/cik-0001672619/424b5/0001193125-26-269621","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-269621-index.html"},{"accession_number":"0001193125-26-266731","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-11","title":"8-K — Enliven Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001672619/8-k/0001193125-26-266731","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-266731-index.html"},{"accession_number":"0001193125-26-267938","form_type":"424B5","form_type_family":"registration","doc_date":"2026-06-11","title":"424B5 — Enliven Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001672619/424b5/0001193125-26-267938","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-267938-index.html"},{"accession_number":"0001193125-26-264085","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-10","title":"8-K — Enliven Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001672619/8-k/0001193125-26-264085","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-264085-index.html"},{"accession_number":"0001701247-26-000007","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Enliven Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001672619/4/0001701247-26-000007","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001701247-26-000007-index.html"},{"accession_number":"0001974158-26-000069","form_type":"144","form_type_family":"other","doc_date":"2026-05-18","title":"144 — Enliven Therapeutics, Inc. — 2026-05-18","url_slug":"/sec/cik-0001672619/144/0001974158-26-000069","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001974158-26-000069-index.html"},{"accession_number":"0001831942-26-000024","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001672619/schedule-13g-a/0001831942-26-000024","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001831942-26-000024-index.html"},{"accession_number":"0001738048-26-000062","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001672619/schedule-13g-a/0001738048-26-000062","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001738048-26-000062-index.html"},{"accession_number":"0001172661-26-002402","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001672619/schedule-13g-a/0001172661-26-002402","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001172661-26-002402-index.html"},{"accession_number":"0001172661-26-002051","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001672619/schedule-13g-a/0001172661-26-002051","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001172661-26-002051-index.html"},{"accession_number":"0001104659-26-062642","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001672619/schedule-13g-a/0001104659-26-062642","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001104659-26-062642-index.html"},{"accession_number":"0000902664-26-002551","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Enliven Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001672619/schedule-13g-a/0000902664-26-002551","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0000902664-26-002551-index.html"}],"related_endpoints":{"profile":"/sec/ELVN/profile","timeline":"/sec/ELVN/timeline","peers":"/sec/ELVN/peers","insider_pulse":"/sec/ELVN/insider-pulse","insider_summary":"/sec/ELVN/insider-summary","insider_transactions":"/sec/ELVN/insider-transactions","form144":"/sec/ELVN/form144","holdings_as_filer":"/sec/ELVN/holdings","financial_facts":"/sec/ELVN/financial-facts","derivatives":"/sec/ELVN/derivatives","officers":"/sec/ELVN/officers","insider_network":"/sec/ELVN/insider-network","risk_flags":"/sec/ELVN/risk-flags","filings":"/sec/ELVN/filings","cross_topic_dossier":"/api/v1/dossier?ticker=ELVN"}}